FOXA1: a transcription factor with parallel functions in development and cancer

Hannenhalli, 2009, The evolution of Fox genes and their role in development and disease, Nat. Rev. Genet., 10, 233, 10.1038/nrg2523

Costa, 1989, Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α1-antitrypsin genes, Mol. Cell. Biol., 9, 1415

Kaestner, 2010, The FoxA factors in organogenesis and differentiation, Curr. Opin. Genet. Dev., 20, 527, 10.1016/j.gde.2010.06.005

Lai, 1991, Hepatocyte nuclear factor 3α belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head, Genes Dev., 5, 416, 10.1101/gad.5.3.416

Weigel, 1989, The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo, Cell, 57, 645, 10.1016/0092-8674(89)90133-5

Pani, 1992, Hepatocyte nuclear factor 3β contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein, Mol. Cell. Biol., 12, 3723

Qian, 1995, Analysis of hepatocyte nuclear factor-3β protein domains required for transcriptional activation and nuclear targeting, Nucleic Acids Res., 23, 1184, 10.1093/nar/23.7.1184

Clark, 1993, Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5, Nature, 364, 412, 10.1038/364412a0

Overdier, 1994, The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix, Mol. Cell. Biol., 14, 2755

Cirillo, 1998, Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome, EMBO J., 17, 244, 10.1093/emboj/17.1.244

Cirillo, 1999, An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA, Mol. Cell, 4, 961, 10.1016/S1097-2765(00)80225-7

Cirillo, 2002, Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4, Mol. Cell, 9, 279, 10.1016/S1097-2765(02)00459-8

Serandour, 2011, Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers, Genome Res., 21, 555, 10.1101/gr.111534.110

Ang, 1993, The formation and maintenance of the definitive endoderm lineage in the mouse: involvement of HNF3/forkhead proteins, Development, 119, 1301, 10.1242/dev.119.4.1301

Monaghan, 1993, Postimplantation expression patterns indicate a role for the mouse forkhead/HNF-3α, β and γ genes in determination of the definitive endoderm, chordamesoderm and neuroectoderm, Development, 119, 567, 10.1242/dev.119.3.567

Sasaki, 1993, Differential expression of multiple fork head related genes during gastrulation and axial pattern formation in the mouse embryo, Development, 118, 47, 10.1242/dev.118.1.47

Kaestner, 1994, The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution, Genomics, 20, 377, 10.1006/geno.1994.1191

Besnard, 2004, Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues, Gene Expr. Patterns, 5, 193, 10.1016/j.modgep.2004.08.006

Friedman, 2006, The Foxa family of transcription factors in development and metabolism, Cell. Mol. Life Sci., 63, 2317, 10.1007/s00018-006-6095-6

Weinstein, 1994, The winged-helix transcription factor HNF-3β is required for notochord development in the mouse embryo, Cell, 78, 575, 10.1016/0092-8674(94)90523-1

Kaestner, 1999, Inactivation of the winged helix transcription factor HNF3α affects glucose homeostasis and islet glucagon gene expression in vivo, Genes Dev., 13, 495, 10.1101/gad.13.4.495

Shih, 1999, Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3α-deficient mice, Proc. Natl. Acad. Sci. U.S.A., 96, 10152, 10.1073/pnas.96.18.10152

Kaestner, 1998, Targeted disruption of the gene encoding hepatocyte nuclear factor 3γ results in reduced transcription of hepatocyte-specific genes, Mol. Cell. Biol., 18, 4245, 10.1128/MCB.18.7.4245

Shen, 2001, Foxa3 (hepatocyte nuclear factor 3γ) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast, J. Biol. Chem., 276, 42812, 10.1074/jbc.M106344200

Behr, 2007, Impaired male fertility and atrophy of seminiferous tubules caused by haploinsufficiency for Foxa3, Dev. Biol., 306, 636, 10.1016/j.ydbio.2007.03.525

Vatamaniuk, 2006, Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation, Diabetes, 55, 2730, 10.2337/db05-0470

Gao, 2008, Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development, Genes Dev., 22, 3435, 10.1101/gad.1752608

Gu, 2002, Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors, Development, 129, 2447, 10.1242/dev.129.10.2447

Gao, 2010, Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature β-cell, Mol. Endocrinol., 24, 1594, 10.1210/me.2009-0513

Behr, 2004, Mild nephrogenic diabetes insipidus caused by Foxa1 deficiency, J. Biol. Chem., 279, 41936, 10.1074/jbc.M403354200

Lee, 2005, The initiation of liver development is dependent on Foxa transcription factors, Nature, 435, 944, 10.1038/nature03649

Li, 2009, Foxa1 and Foxa2 regulate bile duct development in mice, J. Clin. Invest., 119, 1537, 10.1172/JCI38201

Bochkis, 2008, Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress, Nat. Med., 14, 828, 10.1038/nm.1853

Besnard, 2005, Stage-specific regulation of respiratory epithelial cell differentiation by Foxa1, Am. J. Physiol. Lung Cell Mol. Physiol., 289, L750, 10.1152/ajplung.00151.2005

Sawaya, 1994, Two members of the HNF-3 family have opposite effects on a lung transcriptional element; HNF-3α stimulates and HNF-3β inhibits activity of region I from the Clara cell secretory protein (CCSP) promoter, J. Biol. Chem., 269, 22211, 10.1016/S0021-9258(17)31778-7

Clevidence, 1994, Members of the HNF-3/forkhead family of transcription factors exhibit distinct cellular expression patterns in lung and regulate the surfactant protein B promoter, Dev. Biol., 166, 195, 10.1006/dbio.1994.1307

Bohinski, 1994, The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis, Mol. Cell. Biol., 14, 5671

Wan, 2005, Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis, J. Biol. Chem., 280, 13809, 10.1074/jbc.M414122200

Bellusci, 1997, Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis, Development, 124, 53, 10.1242/dev.124.1.53

Pepicelli, 1998, Sonic hedgehog regulates branching morphogenesis in the mammalian lung, Curr. Biol., 8, 1083, 10.1016/S0960-9822(98)70446-4

Song, 2009, A role for forkhead box A1 in acute lung injury, Inflammation, 32, 322, 10.1007/s10753-009-9139-x

Song, 2009, Role of Foxa1 in regulation of bcl2 expression during oxidative-stress-induced apoptosis in A549 type II pneumocytes, Cell Stress Chaperones, 14, 417, 10.1007/s12192-008-0095-4

Ang, 1994, HNF-3β is essential for node and notochord formation in mouse development, Cell, 78, 561, 10.1016/0092-8674(94)90522-3

Ferri, 2007, Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner, Development, 134, 2761, 10.1242/dev.000141

Zetterstrom, 1997, Dopamine neuron agenesis in Nurr1-deficient mice, Science, 276, 248, 10.1126/science.276.5310.248

Simon, 2001, Fate of midbrain dopaminergic neurons controlled by the engrailed genes, J. Neurosci., 21, 3126, 10.1523/JNEUROSCI.21-09-03126.2001

Andersson, 2006, Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2, Development, 133, 507, 10.1242/dev.02224

Lin, 2009, Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development, Dev. Biol., 333, 386, 10.1016/j.ydbio.2009.07.006

Mavromatakis, 2011, Foxa1 and Foxa2 positively and negatively regulate Shh signalling to specify ventral midbrain progenitor identity, Mech. Dev., 128, 90, 10.1016/j.mod.2010.11.002

Ye, 2009, Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice, Gastroenterology, 137, 2052, 10.1053/j.gastro.2009.08.059

van der Sluis, 2008, Forkhead box transcription factors Foxa1 and Foxa2 are important regulators of Muc2 mucin expression in intestinal epithelial cells, Biochem. Biophys. Res. Commun., 369, 1108, 10.1016/j.bbrc.2008.02.158

Gauthier, 2002, Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements, Mol. Endocrinol., 16, 170, 10.1210/mend.16.1.0752

Cunha, 1987, The endocrinology and developmental biology of the prostate, Endocr. Rev., 8, 338, 10.1210/edrv-8-3-338

Donjacour, 1993, Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice, Endocrinology, 132, 2342, 10.1210/endo.132.6.7684975

Peterson, 1997, Hepatocyte nuclear factor-3α promoter regulation involves recognition by cell-specific factors, thyroid transcription factor-1, and autoactivation, Cell Growth Differ., 8, 69

Kopachik, 1998, Expression of hepatocyte nuclear factor-3α in rat prostate, seminal vesicle, and bladder, Dev. Dyn., 211, 131, 10.1002/(SICI)1097-0177(199802)211:2<131::AID-AJA2>3.0.CO;2-I

Mirosevich, 2005, Expression of Foxa transcription factors in the developing and adult murine prostate, Prostate, 62, 339, 10.1002/pros.20131

Gao, 2005, Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation, Development, 132, 3431, 10.1242/dev.01917

Mirosevich, 2006, Expression and role of Foxa proteins in prostate cancer, Prostate, 66, 1013, 10.1002/pros.20299

Bhatia-Gaur, 1999, Roles for Nkx3.1 in prostate development and cancer, Genes Dev., 13, 966, 10.1101/gad.13.8.966

Fan, 2004, Hedgehog signaling promotes prostate xenograft tumor growth, Endocrinology, 145, 3961, 10.1210/en.2004-0079

Karhadkar, 2004, Hedgehog signalling in prostate regeneration, neoplasia and metastasis, Nature, 431, 707, 10.1038/nature02962

Sanchez, 2004, Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling, Proc. Natl. Acad. Sci. U.S.A., 101, 12561, 10.1073/pnas.0404956101

Badve, 2007, FOXA1 expression in breast cancer-correlation with luminal subtype A and survival, Clin. Cancer Res., 13, 4415, 10.1158/1078-0432.CCR-07-0122

Habashy, 2008, Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance, Eur. J. Cancer, 44, 1541, 10.1016/j.ejca.2008.04.020

Sorlie, 2003, Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc. Natl. Acad. Sci. U.S.A., 100, 8418, 10.1073/pnas.0932692100

Feng, 2007, Estrogen receptor-α expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice, Proc. Natl. Acad. Sci. U.S.A., 104, 14718, 10.1073/pnas.0706933104

Mueller, 2002, Mammary gland development in adult mice requires epithelial and stromal estrogen receptor α, Endocrinology, 143, 2357, 10.1210/endo.143.6.8836

Asselin-Labat, 2007, Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation, Nat. Cell Biol., 9, 201, 10.1038/ncb1530

Kouros-Mehr, 2006, GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland, Cell, 127, 1041, 10.1016/j.cell.2006.09.048

Usary, 2004, Mutation of GATA3 in human breast tumors, Oncogene, 23, 7669, 10.1038/sj.onc.1207966

Manuylov, 2007, Fog2 excision in mice leads to premature mammary gland involution and reduced Esr1 gene expression, Oncogene, 26, 5204, 10.1038/sj.onc.1210333

Bernardo, 2010, FOXA1 is an essential determinant of ERα expression and mammary ductal morphogenesis, Development, 137, 2045, 10.1242/dev.043299

Brisken, 1998, A paracrine role for the epithelial progesterone receptor in mammary gland development, Proc. Natl. Acad. Sci. U.S.A., 95, 5076, 10.1073/pnas.95.9.5076

Mallepell, 2006, Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland, Proc. Natl. Acad. Sci. U.S.A., 103, 2196, 10.1073/pnas.0510974103

Neben, 2005, Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype, Oncogene, 24, 1580, 10.1038/sj.onc.1208344

Nucera, 2009, FOXA1 is a potential oncogene in anaplastic thyroid carcinoma, Clin. Cancer Res., 15, 3680, 10.1158/1078-0432.CCR-08-3155

Lin, 2002, The hepatocyte nuclear factor 3α gene, HNF3α (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas, Cancer Res., 62, 5273

Sano, 2010, Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis, Int. J. Oncol., 36, 321

Song, 2010, Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer, Cancer Res., 70, 2115, 10.1158/0008-5472.CAN-09-2979

Pasca di Magliano, 2003, Hedgehog signalling in cancer formation and maintenance, Nat. Rev. Cancer, 3, 903, 10.1038/nrc1229

Dahmane, 2001, The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis, Development, 128, 5201, 10.1242/dev.128.24.5201

Kalkuhl, 1996, Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours, Carcinogenesis, 17, 609, 10.1093/carcin/17.3.609

Lazarevich, 2004, Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors, Hepatology, 39, 1038, 10.1002/hep.20155

Coulouarn, 2009, Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties, Oncogene, 28, 3526, 10.1038/onc.2009.211

Nitsch, 1993, Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements, Proc. Natl. Acad. Sci. U.S.A., 90, 5479, 10.1073/pnas.90.12.5479

O'Brien, 1995, Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes, Mol. Cell. Biol., 15, 1747, 10.1128/MCB.15.3.1747

Roux, 1995, Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene, DNA Cell Biol., 14, 385, 10.1089/dna.1995.14.385

Wang, 1996, Hepatic nuclear factor 3 is an accessory factor required for the stimulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids, Mol. Endocrinol., 10, 794

Christoffels, 1998, Glucocorticoid receptor, C/EBP, HNF3, and protein kinase A coordinately activate the glucocorticoid response unit of the carbamoylphosphate synthetase I gene, Mol. Cell. Biol., 18, 6305, 10.1128/MCB.18.11.6305

Stafford, 2001, Accessory factors facilitate the binding of glucocorticoid receptor to the phosphoenolpyruvate carboxykinase gene promoter, J. Biol. Chem., 276, 39885, 10.1074/jbc.M105370200

Schoneveld, 2004, Structural requirements of the glucocorticoid-response unit of the carbamoyl-phosphate synthase gene, Biochem. J., 382, 463, 10.1042/BJ20040471

Holmqvist, 2005, FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription, Exp. Cell Res., 304, 593, 10.1016/j.yexcr.2004.12.002

Belikov, 2009, FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter, Mol. Cell. Biol., 29, 5413, 10.1128/MCB.00368-09

Uen, 2008, Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death, Int. J. Oncol., 33, 1263

Kasper, 1998, Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer, Lab. Invest., 78, 319

Greenberg, 1995, Prostate cancer in a transgenic mouse, Proc. Natl. Acad. Sci. U.S.A., 92, 3439, 10.1073/pnas.92.8.3439

Gingrich, 1996, Metastatic prostate cancer in a transgenic mouse, Cancer Res., 56, 4096

Chiaverotti, 2008, Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer, Am. J. Pathol., 172, 236, 10.2353/ajpath.2008.070602

Slovin, 2006, Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing?, Nat. Clin. Pract. Urol., 3, 138, 10.1038/ncpuro0435

van der Heul-Nieuwenhuijsen, 2009, Gene expression of forkhead transcription factors in the normal and diseased human prostate, BJU Int., 103, 1574, 10.1111/j.1464-410X.2009.08351.x

Jain, 2011, High-level expression of forkhead-box protein A1 in metastatic prostate cancer, Histopathology, 58, 766, 10.1111/j.1365-2559.2011.03796.x

Sahu, 2011, Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer, EMBO J., 30, 3962, 10.1038/emboj.2011.328

Robbins, 2010, Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors, Genome Res., 21, 47, 10.1101/gr.107961.110

Debes, 2004, Mechanisms of androgen-refractory prostate cancer, N. Engl. J. Med., 351, 1488, 10.1056/NEJMp048178

Gao, 2003, The role of hepatocyte nuclear factor-3α (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes, Mol. Endocrinol., 17, 1484, 10.1210/me.2003-0020

Wang, 2007, A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth, Mol. Cell, 27, 380, 10.1016/j.molcel.2007.05.041

Jia, 2008, Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity, PLoS ONE, 3, e3645, 10.1371/journal.pone.0003645

Lee, 2008, Hepatocyte nuclear factor-3α (HNF-3α) negatively regulates androgen receptor transactivation in prostate cancer cells, Biochem. Biophys. Res. Commun., 367, 481, 10.1016/j.bbrc.2007.12.162

Wang, 2011, Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA, Nature, 474, 390, 10.1038/nature10006

Wang, 2009, Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer, Cell, 138, 245, 10.1016/j.cell.2009.04.056

McMullin, 2009, A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland, Proc. Natl. Acad. Sci. U.S.A., 107, 98, 10.1073/pnas.0902001107

Sreenath, 1999, Androgen-independent expression of hoxb-13 in the mouse prostate, Prostate, 41, 203, 10.1002/(SICI)1097-0045(19991101)41:3<203::AID-PROS8>3.0.CO;2-J

Sun, 2009, Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression, Mol. Endocrinol., 23, 2038, 10.1210/me.2009-0092

Jia, 2009, Functional enhancers at the gene-poor 8q24 cancer-linked locus, PLoS Genet., 5, e1000597, 10.1371/journal.pgen.1000597

Lupien, 2008, FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription, Cell, 132, 958, 10.1016/j.cell.2008.01.018

Eeckhoute, 2009, Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers, Genome Res., 19, 372, 10.1101/gr.084582.108

Yu, 2005, Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially, Ann. N. Y. Acad. Sci., 1061, 77, 10.1196/annals.1336.009

Zhang, 2010, ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer, Cancer Res., 70, 240, 10.1158/0008-5472.CAN-09-2904

Liu, 2005, Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas, Cancer Res., 65, 3796, 10.1158/0008-5472.CAN-04-3823

Zheng, 2006, Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease, Genes Immun., 7, 11, 10.1038/sj.gene.6364263

Zhang, 2005, The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells, Proc. Natl. Acad. Sci. U.S.A., 102, 9890, 10.1073/pnas.0503829102

Scharer, 2009, Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells, Cancer Res., 69, 709, 10.1158/0008-5472.CAN-08-3415

Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093

Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. U.S.A., 98, 10869, 10.1073/pnas.191367098

Early Breast Cancer Trialists' Collaborative Group, 2005, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet, 365, 1687, 10.1016/S0140-6736(05)66544-0

Rakha, 2008, Basal-like breast cancer: a critical review, J. Clin. Oncol., 26, 2568, 10.1200/JCO.2007.13.1748

Wolf, 2006, FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer, Int. J. Cancer., 120, 1013, 10.1002/ijc.22389

Thorat, 2008, Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis, J. Clin. Pathol., 61, 327, 10.1136/jcp.2007.052431

Albergaria, 2009, Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours, Breast Cancer Res., 11, R40, 10.1186/bcr2327

Ademuyiwa, 2009, Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores, Mod. Pathol., 23, 270, 10.1038/modpathol.2009.172

Mehta, 2011, FOXA1 is an independent prognostic marker for ER-positive breast cancer, Breast Cancer Res. Treat.

Hu, 2009, Genetic alterations and oncogenic pathways associated with breast cancer subtypes, Mol. Cancer Res., 7, 511, 10.1158/1541-7786.MCR-08-0107

Doane, 2006, An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen, Oncogene, 25, 3994, 10.1038/sj.onc.1209415

Hall, 1994, MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression, Eur. J. Cancer, 30A, 484, 10.1016/0959-8049(94)90424-3

Naderi, 2008, A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer, Neoplasia, 10, 542, 10.1593/neo.08274

Robinson, 2011, Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1, EMBO J., 30, 3019, 10.1038/emboj.2011.216

Ni, 2011, Targeting androgen receptor in estrogen receptor-negative breast cancer, Cancer Cell, 20, 119, 10.1016/j.ccr.2011.05.026

Robyr, 2000, Determinants of vitellogenin B1 promoter architecture. HNF3 and estrogen responsive transcription within chromatin, J. Biol. Chem., 275, 28291, 10.1074/jbc.M002726200

Beck, 1999, Hepatocyte nuclear factor 3 (winged helix domain) activates trefoil factor gene TFF1 through a binding motif adjacent to the TATAA box, DNA Cell Biol., 18, 157, 10.1089/104454999315547

Carroll, 2005, Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1, Cell, 122, 33, 10.1016/j.cell.2005.05.008

Laganière, 2005, From the cover: location analysis of estrogen receptor α target promoters reveals that FOXA1 defines a domain of the estrogen response, Proc. Natl. Acad. Sci. U.S.A., 102, 11651, 10.1073/pnas.0505575102

Carroll, 2006, Genome-wide analysis of estrogen receptor binding sites, Nat. Genet., 38, 1289, 10.1038/ng1901

Lin, 2007, Whole-genome cartography of estrogen receptor α binding sites, PLoS Genet., 3, e87, 10.1371/journal.pgen.0030087

Charn, 2010, Genome-wide dynamics of chromatin binding of estrogen receptors α and β: mutual restriction and competitive site selection, Mol. Endocrinol., 24, 47, 10.1210/me.2009-0252

Hurtado, 2011, FOXA1 is a key determinant of estrogen receptor function and endocrine response, Nat. Genet., 43, 27, 10.1038/ng.730

Welboren, 2009, ChIP-Seq of ERα and RNA polymerase II defines genes differentially responding to ligands, EMBO J., 28, 1418, 10.1038/emboj.2009.88

Malik, 2010, Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM, Mol. Cell. Biol., 30, 399, 10.1128/MCB.00907-09

Bretschneider, 2008, Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor α-dependent manner, Cancer Res., 68, 106, 10.1158/0008-5472.CAN-07-5647

Yamaguchi, 2008, FoxA1 as a lineage-specific oncogene in luminal type breast cancer, Biochem. Biophys. Res. Commun., 365, 711, 10.1016/j.bbrc.2007.11.064

Eeckhoute, 2006, A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer, Genes Dev., 20, 2513, 10.1101/gad.1446006

Gevry, 2009, Histone H2A.Z is essential for estrogen receptor signaling, Genes Dev., 23, 1522, 10.1101/gad.1787109

Chan, 2008, CCCTC-binding factor confines the distal action of estrogen receptor, Cancer Res., 68, 9041, 10.1158/0008-5472.CAN-08-2632

Zhang, 2010, CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen, J. Biol. Chem., 285, 28604, 10.1074/jbc.M110.149658

Fullwood, 2009, An oestrogen-receptor-α-bound human chromatin interactome, Nature, 462, 58, 10.1038/nature08497

Frasor, 2003, Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype, Endocrinology, 144, 4562, 10.1210/en.2003-0567

Oh, 2006, Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers, J. Clin. Oncol., 24, 1656, 10.1200/JCO.2005.03.2755

McCune, 2010, Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet, Cancer Res., 70, 685, 10.1158/0008-5472.CAN-09-1530

Su, 2007, Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol, J. Biol. Chem., 282, 19385, 10.1074/jbc.M702452200

Krum, 2008, Unique ERα cistromes control cell type-specific gene regulation, Mol. Endocrinol., 22, 2393, 10.1210/me.2008-0100

Sudo, 1983, In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria, J. Cell Biol., 96, 191, 10.1083/jcb.96.1.191

Nakshatri, 2007, FOXA1 as a therapeutic target for breast cancer, Expert Opin. Ther. Targets, 11, 507, 10.1517/14728222.11.4.507

Fu, 2011, More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response, Breast Cancer Res., 13, 307, 10.1186/bcr2849

Sircoulomb, 2010, Genome profiling of ERBB2-amplified breast cancers, BMC Cancer, 10, 539, 10.1186/1471-2407-10-539

Song, 2009, Up-regulation of the HSP72 by Foxa1 in MCF-7 human breast cancer cell line, Biochem. Biophys. Res. Commun., 386, 30, 10.1016/j.bbrc.2009.05.120

Ciocca, 1993, Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications, J. Natl Cancer Inst., 85, 570, 10.1093/jnci/85.7.570

Oloumi, 2010, Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development. Breast Cancer Res, 12, R38

Sinner, 2004, Sox17 and β-catenin cooperate to regulate the transcription of endodermal genes, Development, 131, 3069, 10.1242/dev.01176

Berx, 2001, The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression, Breast Cancer Res., 3, 289, 10.1186/bcr309

Chu, 2008, The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy, Nat. Rev. Cancer, 8, 253, 10.1038/nrc2347

Liu, 2005, Regulatory mechanisms controlling human E-cadherin gene expression, Oncogene, 24, 8277, 10.1038/sj.onc.1208991

Williamson, 2006, BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1), Oncogene, 25, 1391, 10.1038/sj.onc.1209170

Motallebipour, 2009, Differential binding and co-binding pattern of FOXA1 and FOXA3 and their relation to H3K4me3 in HepG2 cells revealed by ChIP-seq, Genome Biol., 10, R129, 10.1186/gb-2009-10-11-r129